Protein misfolding and aggregation in Alzheimer's disease and type 2 diabetes mellitus
- PMID: 25230234
- PMCID: PMC5193501
- DOI: 10.2174/1871527313666140917095514
Protein misfolding and aggregation in Alzheimer's disease and type 2 diabetes mellitus
Abstract
In general, proteins can only execute their various biological functions when they are appropriately folded. Their amino acid sequence encodes the relevant information required for correct three-dimensional folding, with or without the assistance of chaperones. The challenge associated with understanding protein folding is currently one of the most important aspects of the biological sciences. Misfolded protein intermediates form large polymers of unwanted aggregates and are involved in the pathogenesis of many human diseases, including Alzheimer's disease (AD) and Type 2 diabetes mellitus (T2DM). AD is one of the most prevalent neurological disorders and has worldwide impact; whereas T2DM is considered a metabolic disease that detrementally influences numerous organs, afflicts some 8% of the adult population, and shares many risk factors with AD. Research data indicates that there is a widespread conformational change in the proteins involved in AD and T2DM that form β-sheet like motifs. Although conformation of these β-sheets is common to many functional proteins, the transition from α-helix to β-sheet is a typical characteristic of amyloid deposits. Any abnormality in this transition results in protein aggregation and generation of insoluble fibrils. The abnormal and toxic proteins can interact with other native proteins and consequently catalyze their transition into the toxic state. Both AD and T2DM are prevalent in the aged population. AD is characterized by the accumulation of amyloid-β (Aβ) in brain, while T2DM is characterized by the deposition of islet amyloid polypeptide (IAPP, also known as amylin) within beta-cells of the pancreas. T2DM increases pathological angiogenesis and immature vascularisation. This also leads to chronic cerebral hypoperfusion, which results in dysfunction and degeneration of neuroglial cells. With an abundance of common mechanisms underpinning both disorders, a significant question that can be posed is whether T2DM leads to AD in aged individuals and the associations between other protein misfolding diseases.
Conflict of interest statement
The authors confirm that this article content has no conflict of interest.
Figures
Similar articles
-
Molecular interaction between type 2 diabetes and Alzheimer's disease through cross-seeding of protein misfolding.Mol Psychiatry. 2017 Sep;22(9):1327-1334. doi: 10.1038/mp.2016.230. Epub 2017 Jan 3. Mol Psychiatry. 2017. PMID: 28044060 Free PMC article.
-
Amylin as a potential link between type 2 diabetes and alzheimer disease.Ann Neurol. 2019 Oct;86(4):539-551. doi: 10.1002/ana.25570. Epub 2019 Aug 19. Ann Neurol. 2019. PMID: 31376172
-
Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein.Acta Neuropathol Commun. 2021 Apr 8;9(1):64. doi: 10.1186/s40478-021-01171-0. Acta Neuropathol Commun. 2021. PMID: 33832546 Free PMC article.
-
The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins.J Alzheimers Dis. 2017;59(2):421-432. doi: 10.3233/JAD-161192. J Alzheimers Dis. 2017. PMID: 28269785 Review.
-
Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.Chem Rev. 2021 Feb 24;121(4):2545-2647. doi: 10.1021/acs.chemrev.0c01122. Epub 2021 Feb 5. Chem Rev. 2021. PMID: 33543942 Free PMC article. Review.
Cited by
-
Tuning the surface charge of phospholipid bilayers inhibits insulin fibrilization.Colloids Surf B Biointerfaces. 2022 Dec;220:112904. doi: 10.1016/j.colsurfb.2022.112904. Epub 2022 Oct 13. Colloids Surf B Biointerfaces. 2022. PMID: 36265317 Free PMC article.
-
Non-equilibrium physics of multi-species assembly applied to fibrils inhibition in biomolecular condensates and growth of online distrust.Sci Rep. 2024 Sep 19;14(1):21911. doi: 10.1038/s41598-024-72538-1. Sci Rep. 2024. PMID: 39300202 Free PMC article.
-
Redox proteomics and amyloid β-peptide: insights into Alzheimer disease.J Neurochem. 2019 Nov;151(4):459-487. doi: 10.1111/jnc.14589. Epub 2018 Nov 27. J Neurochem. 2019. PMID: 30216447 Free PMC article. Review.
-
Intrinsically disordered proteins identified in the aggregate proteome serve as biomarkers of neurodegeneration.Metab Brain Dis. 2022 Jan;37(1):147-152. doi: 10.1007/s11011-021-00791-8. Epub 2021 Aug 4. Metab Brain Dis. 2022. PMID: 34347206 Free PMC article. Review.
-
Biflavonoid-Induced Disruption of Hydrogen Bonds Leads to Amyloid-β Disaggregation.Int J Mol Sci. 2021 Mar 12;22(6):2888. doi: 10.3390/ijms22062888. Int J Mol Sci. 2021. PMID: 33809196 Free PMC article.
References
-
- Chen W, Liu X, Huang Y, Jiang Y, Zou Q, Lin C. Improved method for predicting protein fold patterns with ensemble classifiers. Genet Mol Res. 2012;11(1):174–181. - PubMed
-
- Brito RMM, Dubitzky W, Rodrigues JR. Protein folding and unfolding simulations: a new challenge for data mining. OMICS. 2004;8(2):153–166. - PubMed
-
- Bai Y, Nussinov R. Protein Folding Protocols. Springer; 2007.
-
- Dobson CM, Evans PA, Radford SE. Understanding how proteins fold: the lysozyme story so far. Trends Biochem Sci. 1994;19(1):31–37. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical